# Adagio Medical Holdings, Inc.: filings

ADGM · Nasdaq · CIK 2006986 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adgm.md) · [Financials](/companies/adgm/financials.md) · [Filings](/companies/adgm/filings.md) · [Insiders](/companies/adgm/insiders.md)

## Reports and events: 60 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (424B3 54, 8-K 38, 4 24, 3 15, SCHEDULE 13G/A 11, 425 10, CORRESP 10, EFFECT 10, POS AM 8, UPLOAD 8, 10-Q 7, S-1 4, SCHEDULE 13G 4, DEF 14A 3, S-4/A 3, S-8 3, 10-K 2, 10-K/A 2, 8-K/A 2, ARS 2, S-1/A 2, SC 13G 2, 8-A12B 1, CERT 1, D 1, DEFA14A 1, DRS 1, PRE 14A 1, S-3 1, S-4 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 08:00 ET | [8-K](/filings/0001104659-26-118615.md) | 5.07 Shareholder vote results | 0001104659-26-118615 |
| 2026-10-13 | 06:02 ET | [DEF 14A](/filings/0001140361-26-039339.md) | Proxy statement, period 2026-10-23 | 0001140361-26-039339 |
| 2026-10-01 | 17:08 ET | [8-K](/filings/0001104659-26-112887.md) | 3.02 Unregistered sale of equity | 0001104659-26-112887 |
| 2026-09-23 | 08:01 ET | [8-K](/filings/0001104659-26-109821.md) | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109821 |
| 2026-08-14 | 16:31 ET | [8-K](/filings/0001104659-26-097242.md) | 3.01 Delisting notice | 0001104659-26-097242 |
| 2026-08-13 | 16:37 ET | [8-K](/filings/0001104659-26-095987.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-095987 |
| 2026-08-11 | 08:30 ET | [10-Q](/filings/0001104659-26-093790.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093790 |
| 2026-08-11 | 08:30 ET | [8-K](/filings/0001104659-26-093791.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-093791 |
| 2026-07-13 | 06:00 ET | [10-K/A](/filings/0001104659-26-082769.md) | Annual report, amended, period 2025-12-31 | 0001104659-26-082769 |
| 2026-06-16 | 17:26 ET | [8-K](/filings/0001104659-26-074709.md) | 5.07 Shareholder vote results | 0001104659-26-074709 |
| 2026-06-12 | 16:32 ET | [8-K](/filings/0001104659-26-073517.md) | 3.01 Delisting notice | 0001104659-26-073517 |
| 2026-05-21 | 16:31 ET | [8-K](/filings/0001104659-26-065180.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065180 |
| 2026-05-12 | 08:05 ET | [10-Q](/filings/0001104659-26-059027.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059027 |
| 2026-05-12 | 08:05 ET | [8-K](/filings/0001104659-26-059026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059026 |
| 2026-04-30 | 17:05 ET | [DEF 14A](/filings/0001140361-26-018313.md) | Proxy statement, period 2026-06-16 | 0001140361-26-018313 |
| 2026-04-27 | 06:03 ET | [8-K](/filings/0001104659-26-048833.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-048833 |
| 2026-04-20 | 16:34 ET | [8-K](/filings/0001104659-26-045536.md) | 5.08 Item not in the standard list | 0001104659-26-045536 |
| 2026-04-08 | 08:00 ET | [8-K](/filings/0001104659-26-040673.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-040673 |
| 2026-03-27 | 08:42 ET | [10-K](/filings/0002006986-26-000003.md) | Annual report, period 2025-12-31 | 0002006986-26-000003 |
| 2026-03-27 | 08:00 ET | [8-K](/filings/0001104659-26-035699.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-035699 |
| 2025-12-16 | 16:15 ET | [8-K](/filings/0001104659-25-121586.md) | 5.07 Shareholder vote results | 0001104659-25-121586 |
| 2025-12-11 | 17:17 ET | [8-K](/filings/0001104659-25-120352.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-120352 |
| 2025-11-12 | 16:07 ET | [10-Q](/filings/0001104659-25-110345.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110345 |
| 2025-11-12 | 16:05 ET | [8-K](/filings/0001104659-25-110336.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110336 |
| 2025-11-04 | 16:07 ET | [DEF 14A](/filings/0001140361-25-040334.md) | Proxy statement, period 2025-12-15 | 0001140361-25-040334 |
| 2025-10-24 | 16:25 ET | [8-K](/filings/0001104659-25-102156.md) | 5.08 Item not in the standard list | 0001104659-25-102156 |
| 2025-10-20 | 13:04 ET | [8-K](/filings/0001104659-25-100727.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100727 |
| 2025-10-15 | 08:05 ET | [8-K](/filings/0001104659-25-099535.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-099535 |
| 2025-10-10 | 15:41 ET | [8-K](/filings/0001104659-25-098701.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-098701 |
| 2025-10-01 | 08:01 ET | [8-K](/filings/0001104659-25-095343.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-095343 |
| 2025-09-08 | 08:00 ET | [8-K](/filings/0001104659-25-088048.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-088048 |
| 2025-08-14 | 18:23 ET | [10-Q](/filings/0001558370-25-011420.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011420 |
| 2025-08-13 | 17:22 ET | [8-K](/filings/0001558370-25-011411.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011411 |
| 2025-05-15 | 16:15 ET | [10-Q](/filings/0001558370-25-007883.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007883 |
| 2025-05-15 | 16:10 ET | [8-K](/filings/0001104659-25-049436.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-049436 |
| 2025-04-30 | 16:05 ET | [10-K/A](/filings/0001410578-25-001044.md) | Annual report, amended, period 2024-12-31 | 0001410578-25-001044 |
| 2025-04-23 | 16:05 ET | [8-K](/filings/0001558370-25-005261.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-25-005261 |
| 2025-04-02 | 17:13 ET | [8-K](/filings/0001104659-25-031255.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-031255 |
| 2025-03-27 | 17:10 ET | [10-K](/filings/0001558370-25-003849.md) | Annual report, period 2024-12-31 | 0001558370-25-003849 |
| 2025-03-17 | 16:01 ET | [8-K](/filings/0001104659-25-024408.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-024408 |
| 2025-03-04 | 16:15 ET | [8-K](/filings/0001104659-25-020319.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-020319 |
| 2025-02-28 | 08:32 ET | [8-K](/filings/0001104659-25-018724.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-018724 |
| 2025-02-05 | 14:24 ET | [8-K](/filings/0001104659-25-009533.md) | 1.02 Termination of a material agreement | 0001104659-25-009533 |
| 2025-02-04 | 17:16 ET | [S-1/A](/filings/0001104659-25-009194.md) | Registration statement, amended | 0001104659-25-009194 |
| 2025-02-04 | 17:14 ET | [S-1/A](/filings/0001104659-25-009185.md) | Registration statement, amended | 0001104659-25-009185 |
| 2025-01-14 | 07:50 ET | [S-1](/filings/0001104659-25-003291.md) | Registration statement | 0001104659-25-003291 |
| 2025-01-14 | 06:28 ET | [S-1](/filings/0001104659-25-003193.md) | Registration statement | 0001104659-25-003193 |
| 2025-01-06 | 17:10 ET | [8-K](/filings/0001104659-25-001387.md) | 1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001104659-25-001387 |
| 2024-12-23 | 16:05 ET | [8-K](/filings/0001558370-24-016460.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001558370-24-016460 |
| 2024-12-16 | 09:00 ET | [8-K](/filings/0001558370-24-016265.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-016265 |

Page 1 of 2. [Older](/companies/adgm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 08:01 ET. No prices; not investment advice.